Provided by Tiger Trade Technology Pte. Ltd.

Johnson & Johnson

268.47
+2.891.09%
Volume:983.21K
Turnover:264.78M
Market Cap:646.81B
PE:31.09
High:271.54
Open:270.89
Low:268.01
Close:265.58
52wk High:281.07
52wk Low:173.33
Shares:2.41B
Float Shares:2.40B
Volume Ratio:0.65
T/O Rate:0.04%
Dividend:5.24
Dividend Rate:1.95%
EPS(TTM):8.64
EPS(LYR):11.03
ROE:25.74%
ROA:8.59%
PB:7.61
PE(LYR):24.33

Loading ...

Johnson & Johnson Partners with Sail Biomedicines on in Vivo CAR-T Programs, Takes Option to Buy Sail for $2.58 Billion

Reuters
·
Jul 30

Johnson & Johnson Makes $465 Million Equity Investment in Sail Biomedicines

Reuters
·
Jul 30

Johnson & Johnson Lowers 2026 Profit Forecast

Reuters
·
Jul 30

Johnson & Johnson Completes USD 1 Billion Acquisition of Firefly Bio

Reuters
·
Jul 30

JNJ enters strategic agreement to acquire Sail Biomedicines for $2.58B

TIPRANKS
·
Jul 30

Johnson & Johnson cuts FY26 EPS view to $10.86-$11.01, consensus $11.68

TIPRANKS
·
Jul 30

Johnson & Johnson affirms FY26 revenue view of $100.8B-$101.4B

TIPRANKS
·
Jul 30

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 30

Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in Vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset

THOMSON REUTERS
·
Jul 30

J&J: Granted Exclusive Option to Acquire Sail Biomedicines for $2.58Bln

THOMSON REUTERS
·
Jul 30

J&J: Johnson & Johnson Will Also Make an Equity Investment in Sail

THOMSON REUTERS
·
Jul 30

Johnson & Johnson Fy2026 Shr View $11.69

THOMSON REUTERS
·
Jul 30

J&J Outlook FY Adj EPS $10.96 - $11.11

THOMSON REUTERS
·
Jul 30

J&J - Enters Strategic Agreements with Sail Biomedicines - SEC Filing

THOMSON REUTERS
·
Jul 30

J&J: Under Terms of the Agreements with Sail, Johnson & Johnson Would Make Total Initial Payments of $785 Million

THOMSON REUTERS
·
Jul 30

Can J&J Finally Put the Talc Litigation Behind It?

Reuters
·
Jul 29

Johnson & Johnson price target raised to $300 from $290 at Argus

TIPRANKS
·
Jul 29

J&J : Argus Research Raises Target Price to $300 from $290

THOMSON REUTERS
·
Jul 29

Argus Research Adjusts Johnson & Johnson Price Target to $300 From $290, Maintains Buy Rating

MT Newswires Live
·
Jul 29

Johnson & Johnson (JNJ) Stock May Be 31% Below Fair Value On Talc Settlement

Simply Wall St.
·
Jul 29